SUIT-026 O2 mt D063: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
|abbr=RET (respiratory control) of [[SUIT-026 AmR mt D064]] | |abbr=RET (respiratory control) of [[SUIT-026 AmR mt D064]] | ||
|description=[[File:1S;2Rot;3D;3c;4Ama.png|400px]] | |description=[[File:1S;2Rot;3D;3c;4Ama.png|400px]] | ||
|info='''B''' - '''[[SUIT-026]]''' ย | |info='''B''' - '''[[SUIT-026]]''' - Protocol for the respiratory control of [[SUIT-026 AmR mt D064]] | ||
|application=O2 | |application=O2 | ||
|SUIT number=D063_1S;2Rot;3D;3c;4Ama | |SUIT number=D063_1S;2Rot;3D;3c;4Ama | ||
}} | }} | ||
{{Template:SUIT text D063}} | {{Template:SUIT text D063}} | ||
Line 32: | Line 30: | ||
::::* [[SUIT-006 O2 mt D022]]: CCP mtprep for S-pathway. | ::::* [[SUIT-006 O2 mt D022]]: CCP mtprep for S-pathway. | ||
== Chemicals and syringes == | |||
{{Template:Chemicals SUIT-026 O2 mt D063}} | |||
::: Suggested stock concentrations are shown in the specific DL-Protocol. | |||
Revision as of 12:42, 18 September 2020
Description
Abbreviation: RET (respiratory control) of SUIT-026 AmR mt D064
Reference: B - SUIT-026 - Protocol for the respiratory control of SUIT-026 AmR mt D064
SUIT number: D063_1S;2Rot;3D;3c;4Ama
O2k-Application: O2
SUIT-026 O2 mt D063 has been designed to serve as a respiratory control of the SUIT-026 AmR mt D064 (protocol to study the RET-initiated ROS production in mitochondrial preparations (isolated mitochondria, tissue homogenate and permeabilized cells which are already permeabilized when they are added to the chamber).
Communicated by Komlodi T, Iglesias-Gonzalez J and Gnaiger E (last update 2019-09-24)
Representative traces
Steps and respiratory states
Step | State | Pathway | Q-junction | Comment - Events (E) and Marks (M) |
---|---|---|---|---|
1S | SL(n) | S | CII | 1S
|
2Rot | SL(n) | S | CII | 1S;2Rot
|
3D | SP | S | CII | 1S;2Rot;3D
|
3c | SP | S | CII | 1S;2Rot;3D;3c
|
4Ama | ROX | 1S;2Rot;3D;3c;4Ama
|
- Bioblast links: SUIT protocols - >>>>>>> - Click on [Expand] or [Collapse] - >>>>>>>
- Coupling control
- Pathway control
- ยป Electron transfer pathway
- ยป Fatty acid oxidation pathway control state, F
- ยป NADH electron transfer-pathway state, N
- ยป Succinate pathway control state, S
- ยป NS-pathway control state, NS
- ยป Glycerophosphate pathway control state, Gp
- ยป Complex IV single step, CIV
- ยป Anaplerotic pathway control state
- Pathway control
- Main fuel substrates
- ยป Glutamate, G
- ยป Glycerophosphate, Gp
- ยป Malate, M
- ยป Octanoylcarnitine, Oct
- ยป Pyruvate, P
- ยป Succinate, S
- Main fuel substrates
- Glossary
Strengths and limitations
- This protocol serves as a respiratory control (since fluorescence dyes may inhibit components of the ET system) and quality control for the sample for SUIT-026 AmR mt D064.
- + Short protocol.
- + The addition of cytochrome c to assess the mt outer membrane integrity provides a quality control of the sample, which cannot be performed in the protocol with Amplex UltraRed.
- - This protocol does not provide information about all the coupling control states (LEAK, OXPHOS and ET). However, it is possible to create a DLPU by additing an Event&Mark for the uncoupler titration (4U) after ADP (3D) to obtain ET-state.
Compare SUIT protocols
- SUIT-026 AmR mt D064: Protocol to evaluate the RET production of ROS.
- SUIT-006 O2 mt D022: CCP mtprep for S-pathway.
Chemicals and syringes
Step | Chemical(s) and link(s) | Comments |
---|---|---|
1S | Succinate (S) | |
2Rot | Rotenone (Rot) | |
3D | ADP (D) | |
3c | Cytochrome c (c) | |
4Ama | Antimycin A (Ama) |
- Suggested stock concentrations are shown in the specific DL-Protocol.
References
MitoPedia concepts: SUIT protocol, SUIT B, Find
MitoPedia methods:
Fluorometry